Significant prognostic improvement in elderly patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax: outcomes from a retrospective real-world analysis
The integration of hypomethylating agents and venetoclax into the treatment paradigm for elderly patients with AML has significantly enhanced survival rates.
Authors
- Ruyu Cai
- Yong Wu (ORCID: https://orcid.org/0000-0002-2873-0334)
- Yi Chen (ORCID: https://orcid.org/0000-0003-4552-461X)
- Zhengyang Wang (ORCID: https://orcid.org/0000-0003-3244-1954)
- Jing Zheng (ORCID: https://orcid.org/0000-0003-1747-5398)
- Zhengjun Wu
- Jiayi Zhou (ORCID: https://orcid.org/0000-0001-7204-2662)
- Lanlan Wu
Institutions
- Fujian Medical University (CN)
- Union Hospital (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2025-06-02
- DOI
- https://doi.org/10.1080/07853890.2025.2512120
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Fujian Province